Detalhe da pesquisa
1.
LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells.
Immunity
; 49(1): 120-133.e9, 2018 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30005826
2.
Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus.
N Engl J Med
; 386(11): 1034-1045, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294813
3.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I).
Lancet
; 401(10381): 1001-1010, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848918
4.
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II).
Lancet
; 401(10381): 1011-1019, 2023 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36848919
5.
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Ann Rheum Dis
; 83(3): 360-371, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932009
6.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827694
7.
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
J Autoimmun
; 142: 103148, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967495
8.
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
Lancet
; 399(10320): 161-171, 2022 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861168
9.
Altered increase in STAT1 expression and phosphorylation in severe COVID-19.
Eur J Immunol
; 52(1): 138-148, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676541
10.
Resident memory CD4+ T lymphocytes mobilize from bone marrow to contribute to a systemic secondary immune reaction.
Eur J Immunol
; 52(5): 737-752, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35245389
11.
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 82(1): 48-56, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35260387
12.
Differences in labour market marginalisation between refugees, non-refugee immigrants and Swedish-born youth: Role of age at arrival and residency duration.
Scand J Public Health
; 51(3): 391-402, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35343330
13.
[Practicable diagnostics of Sjögren's syndrome in interstitial lung disease-A discussion article]. / Praktikable Sjögren-Diagnostik bei interstitieller Lungenerkrankung ein Diskussionsbeitrag.
Z Rheumatol
; 82(4): 321-324, 2023 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-36949162
14.
B cells in systemic lupus erythematosus.
Curr Opin Rheumatol
; 34(2): 125-132, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34939607
15.
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies.
J Clin Immunol
; 42(6): 1111-1129, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511314
16.
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).
Eur J Immunol
; 51(12): 2708-3145, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910301
17.
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus.
Ann Rheum Dis
; 2022 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609978
18.
Biological impact of iberdomide in patients with active systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477518
19.
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Ann Rheum Dis
; 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798534
20.
Advances in SLE classification criteria.
J Autoimmun
; 132: 102845, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725680